Year-over-year, this metric declined by 100.0%, from $10.72M to $0.00.
An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.
This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...
Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.
proceeds_from_sale_of_business| FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|
| Value | $0.00 | $0.00 | $42.89M | $0.00 |
| YoY Change | — | — | — | -100.0% |